Committee approves grant of up to 68,982 stock options at Rs. 1,374.40 each
Committee approved on Nov 4, 2026 a grant of up to 68,982 stock options under Stock Option Plan 2026, covering up to 68,982 equity shares of Re. 1/- face value.
By ScoutQuest · · 2 min read
- Stock Options Granted
- up to 68,982 stock options
- Exercise Price
- Rs. 1,374.40
- Vesting / Exercise Period
- vesting up to 5 years; exercise period 5 years from vesting
What was announced
Rubicon Research has told the stock exchanges that its Nomination and Remuneration Committee approved a grant of stock options on November 4, 2026, under the Rubicon Research Limited Stock Option Plan 2026.
The grant in numbers
- Number of stock options granted: up to 68,982
- Shares covered by these options: up to 68,982 equity shares of face value Re. 1/- each
- Exercise price / grant price: Rs. 1,374.40 per option
- Vesting period: up to 5 years from the date of grant
- Exercise period: 5 years from the date of vesting
- The update states the scheme is in terms of SEBI (SBEB) Regulations, 2021
What a stock option grant means
An employee stock option is a right given to employees to buy the company's shares later at a pre-fixed price. Here that pre-fixed price is Rs. 1,374.40 per share, which is far above the Re. 1/- face value of the share. The employee pays this amount only when the option is exercised, and only after the option has vested.
Because vesting is spread over a period of up to 5 years from the grant date, the options become exercisable in stages rather than all at once. After vesting, the holder has a further 5 years from the date of vesting to exercise the option.
What it means for existing shareholders
If all the options are exercised, up to 68,982 new equity shares of face value Re. 1/- each would be issued, and the company would receive Rs. 1,374.40 per share exercised. This is the money that comes into the company when options are exercised.
The update sets out the number of options, the shares they cover, the exercise price and the timing. It is an intimation of an employee compensation decision by the committee, giving shareholders the parameters of the grant.
Also from Rubicon Research
Rubicon Research Q2 FY27 investor presentation: revenue up 39.9%, PAT up 67.9%
5 Nov 2026
Board approves Q2 and H1 results; auditor review conclusion unmodified
5 Nov 2026
USFDA issues Form 483 with 5 procedural observations after Ambernath plant inspection
30 Oct 2026
More numbers
- Stock options grantedupto 68,982 stock options
- Equity shares covered by the optionsUpto 68,982 Equity shares
- Exercise price / grant price per optionRs. 1,374.40/-
- Face value per equity shareRe. 1/-
- Vesting period from date of grantUpto 5 years
- Exercise period from date of vesting5 years
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.